Reactive Changes in Lymph Node Structure in Peritonitis and during Treatment with a New Antibiotic

Area of Science:

• Immunology
• Microbiology
• Pathology

Background:

• Peritonitis causes significant changes in mesenteric lymph nodes, impairing immune function.
• These changes include reduced cortical structures and expanded sinus systems, suggesting decreased drainage and detoxification.
• Such alterations are linked to unfavorable peritonitis outcomes.

Purpose of the Study:

• To investigate the effects of the novel antibiotic peptomide A-70 on mesenteric lymph nodes during experimental peritonitis.
• To evaluate how peptomide A-70 influences the morphological and functional responses of lymph nodes to peritoneal inflammation.

Main Methods:

• Induction of experimental peritonitis in rats.
• Administration of the antibiotic peptomide A-70.
• Morphological analysis of rat mesenteric lymph nodes.

Main Results:

• Peritonitis led to lymph node changes indicative of reduced immune and drainage functions.
• Peptomide A-70 treatment mitigated inflammatory and toxic effects on the lymph system.
• Antibiotic therapy promoted lymphopoiesis and immune response, evidenced by increased lymph node size and T-dependent zones, and reduced sinus expansion.

Conclusions:

• Peptomide A-70 effectively counteracts the detrimental effects of peritonitis on mesenteric lymph nodes.
• The antibiotic potentiates lymph node immune and lymphopoietic functions, leading to a favorable prognosis.
• These findings highlight peptomide A-70 as a promising therapeutic agent for peritonitis.